eHealth, Inc. to Present at Credit Suisse Virtual Healthcare Conference

SANTA CLARA, Calif., Nov. 3, 2020 /PRNewswire/ — eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance marketplace, today announced that its management will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Wednesday, November 11, 2020 at 2:00 p.m. E.T.  Interested investors can access the live audio webcast of eHealth’s presentation at www.ehealthinsurance.com under Investor Relations. Please visit the website at least 15 minutes early to register, download, and install any necessary software. A replay of this event will be available on the company’s website shortly after the conclusion of the event and will remain available for 14 days.

About eHealth, Inc.
eHealth, Inc. (NASDAQ: EHTH) operates a leading health insurance marketplace at eHealth.com and eHealthMedicare.com with technology that provides consumers with health insurance enrollment solutions. Since 1997, we have connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans. Our proprietary marketplace offers Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual, family, small business and other plans from over 180 health insurance carriers across fifty states and the District of Columbia.

Investor Contact:
Kate Sidorovich, CFA
Vice President Investor Relations
650-210-3111
Kate.sidorovich@ehealth.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ehealth-inc-to-present-at-credit-suisse-virtual-healthcare-conference-301166074.html

SOURCE eHealth, Inc.

Staff

Recent Posts

AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio

ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…

16 minutes ago

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

6 hours ago